The Patient Activation Measure: a validation study in a neurological population

Packer, Tanya; Kephart, George; Ghahari, Setareh; Audulv, Åsa; Versnel, Joan; Warner, Grace

doi:10.1007/s11136-014-0908-0

Cited by 36 publications

(44 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding is similar to the explaining variance calculated in the German study (40.9 %) and in the Norwegian one (37.94 %) thus suggesting that additional factors explaining variance may be considered. This hypothesis is also embraced by studies carried on the neurological population [ 22 , 31 , 53 ]. The latter study performed a confirmatory factory analysis and suggested a tri-factor solutions as the optimal one.…”

Section: Discussionmentioning

confidence: 94%

Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)

Graffigna

Barello

Bonanomi

et al. 2015

BMC Med Inform Decis Mak

View full text Add to dashboard Cite

BackgroundThe Patient Activation Measure (PAM13) is an instrument that assesses patient knowledge, skills, and confidence for disease self-management. This cross-sectional study was aimed to validate a culturally-adapted Italian Patient Activation Measure (PAM13-I) for patients with chronic conditions.Methods519 chronic patients were involved in the Italian validation study and responded to PAM13-I. The PAM 13 was translated into Italian by a standardized forward-backward translation. Data quality was assessed by mean, median, item response, missing values, floor and ceiling effects, internal consistency (Cronbach's alpha and average inter-item correlation), item-rest correlations. Rasch Model and differential item functioning assessed scale properties.ResultsMean PAM13-I score was 66.2. Rasch analysis showed that the PAM13-I is a good measure of patient activation. The level of internal consistency was good (α = 0.88). For all items, the distribution of answers was left-skewed, with a small floor effect (range 1.7–4.5 %) and a moderate ceiling effect (range 27.6–55.0 %). The Italian version formed a unidimensional, probabilistic Guttman-like scale explaining 41 % of the variance.ConclusionThe PAM13-I has been demonstrated to be a valid and reliable measure of patient activation and the present study suggests its applicability to the Italian-speaking chronic patient population. The measure has good psychometric properties and appears to be consistent with the developmental nature of the patient activation phenomenon, although it presents a different ranking order of the items comparing to the American version.PAM13-I can be a useful assessment tool to evaluate interventions aimed at improving patient engagement in healthcare and to train doctors in attuning their communication to the level of patients’ activation. Future research could be conducted to further confirm the validity of the PAM13-I.

show abstract

Section: Discussionmentioning

confidence: 94%

Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)

Graffigna

Barello

Bonanomi

et al. 2015

BMC Med Inform Decis Mak

View full text Add to dashboard Cite

show abstract

“…The transformation is based on the new index-scale by Insignia [ 24 ]. PAM has been validated among several patient groups with various chronic diseases [ 15 , 25 – 27 ]. In this study, we used the Norwegian back-translated PAM [ 28 ], which has been validated in mental health populations [ 29 ].…”

Section: Methodsmentioning

confidence: 99%

Short time effect of a self-referral to inpatient treatment for patients with severe mental disorders: a randomized controlled trial

Moljord

Helland-Hansen

Salvesen

et al. 2016

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundService user participation is a central principle in mental healthcare, and the opportunity to self-refer to inpatient treatment is used to increase service user involvement and activation. The aim of this study was to investigate the short-term effect of a self-referral system in an inpatient rehabilitation unit at a community mental health center on patient activation and recovery in individuals with severe mental disorders.MethodsA randomized controlled study including 53 patients (41 % females, mean age 40 years). Twenty-six patients in the intervention group were given a contract for self-referral to inpatient treatment, limited to maximum 5 days and a quarantine time of 14 days between each stay. The control group (27 participants) received treatment as usual, and was offered the intervention after 1 year. The Patient Activation Measure was the primary outcome and secondary outcome was the Recovery Assessment Scale. Mixed models were used to assess group differences.ResultsDuring the 4 months period, 15 (58 %) of 26 participants in the intervention group used the contract of self-referral to inpatient treatment. The intervention group had more admissions than the control group but both groups had a similar total use of inpatient days and out-patient consultations. The self-referral to inpatient treatment counted for 11 % of all inpatient days for the intervention group. There were no significant differences in the outcome between the groups on patient activation (estimated mean difference 2.7, 95 % confidence interval = −5.5 to 10.8, p = 0.52) or recovery (estimated mean difference 0.01, 95 % confidence interval = −0.3 to 0.3, p = 0.92).ConclusionsGiving persons with severe mental disorders the possibility to self-refer to inpatient treatment did not change their level of patient activation and recovery after 4 months and did not lead to increased use of health services. The cost-effectiveness and long-term effect of self-referral to inpatient treatment should be investigated further.Trial registrationNCT01133587, clinicaltrials.gov.

show abstract

“…Previous research has demonstrated that psychometrically, the PAM 13 has stronger and more detailed all round validity in demonstrating clear face, content, construct and criterion validity and psychometric reliability across populations (14,(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27). A large body of evidence therefore demonstrates that the PAM-13 is a valid, reliable and clinically useful measure of patient activation that can be used across diverse cultures and patient groups.…”

Section: Limitations Of the Promsmentioning

confidence: 98%

“…The PAM 13, a short-form version of the PAM 22, has been more extensively examined for use in additional populations and languages (14) . It offers strong psychometric evidence in people living with long term conditions (16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27). The PAM; specifically the PAM-13, possesses a large body of evidence that supports its strong psychometric properties across diverse cultures and patient groups.…”

Section: Introductionmentioning

confidence: 99%

Eliciting the impact of digital consulting for young people living with long term conditions (LYNC study): which Patient Reported Outcome Measure? (Preprint)

Sturt¹,

Dliwayo²,

Forjaz³

et al. 2018

Preprint

View full text Add to dashboard Cite

show abstract

The Patient Activation Measure: a validation study in a neurological population

Abstract: The PAM-13 is an internally reliable and valid tool for research purposes. The use of categorical activation "level" in clinical settings should be done with caution.

Cited by 36 publications

References 40 publications

Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)

Measuring patient activation in Italy: Translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I)

Short time effect of a self-referral to inpatient treatment for patients with severe mental disorders: a randomized controlled trial

Eliciting the impact of digital consulting for young people living with long term conditions (LYNC study): which Patient Reported Outcome Measure? (Preprint)

Contact Info

Product

Resources

About